Literature DB >> 22284258

Human papillomavirus detected in esophageal squamous cell carcinoma in Iran.

Afshin Abdirad1, Neda Eram, Ashkan Heshmatzade Behzadi, Chihaya Koriyama, Nima Parvaneh, Suminori Akiba, Takuya Kato, Noureen Kahn, Mohiedean Ghofrani, Nader Sadigh.   

Abstract

INTRODUCTION: Considering the different results obtained regarding the association of HPV with the development of esophageal squamous cell carcinoma (ESCC) in different populations, we aimed to determine the frequency of HPV infection and its subtypes in ESCC in Iranian patients.
METHOD: A total of 100 paraffin-embedded tissue samples of ESCC diagnosed during 1991 and 2005 in the Institute of Cancer affiliated to Tehran University of Medical Sciences were selected. Seven out of 100 samples were excluded due to low quality of extracted DNA from paraffin-embedded specimens. Thus, 93 samples were included for HPV genotyping. RESULT: All samples were examined using SPF10 primers for HPV detection. HPV DNA was positive in 8 out of 93 (8.6%) ESCC specimens. Using INNO-LiPA genotyping system we detected the genotypes of 5 out of 8 HPV-positive samples. Both HPV types 16 and 6 were detected in 3 specimens; one sample was positive for HPV type 18 and 2 samples were co-infected with two HPV types. There were no statistically significant differences between HPV-positive and HPV-negative cases with regard to clinical and pathologic findings. Three samples were positive for SPF10 indicating HPV infection; however, the exact HPV type could not be clarified using INNO-LiPA genotyping .
CONCLUSION: In conclusion, the present study showed that a small proportion of ESCC specimens from Iran harbor HPV16, 18 genome using a highly sensitive method. As different rates have been reported from Iran, a more widespread study with more precise definition of geographical differences could delineate the potential involvement of HPV in the development of ESCC in Iranian population.
Copyright © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22284258     DOI: 10.1016/j.ejim.2011.06.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

1.  Incidence of human papilloma virus in esophageal squamous cell carcinoma in patients from the Lublin region.

Authors:  Andrzej Dąbrowski; Wojciech Kwaśniewski; Tomasz Skoczylas; Wiesława Bednarek; Dorota Kuźma; Anna Goździcka-Józefiak
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 2.  Human papillomavirus and gastrointestinal cancer in Iranian population: A systematic review and meta-analysis.

Authors:  Versa Omrani-Navai; Reza Alizadeh-Navaei; Yousef Yahyapour; Akbar Hedayatizadeh-Omran; Saeid Abediankenari; Ghasem Janbabaei; Fatima Toghani
Journal:  Caspian J Intern Med       Date:  2017

3.  Relationships of early esophageal cancer with human papillomavirus and alcohol metabolism.

Authors:  Masaki Inoue; Yuichi Shimizu; Marin Ishikawa; Satoshi Abiko; Yoshihiko Shimoda; Ikko Tanaka; Sayoko Kinowaki; Masayoshi Ono; Keiko Yamamoto; Shoko Ono; Naoya Sakamoto
Journal:  World J Gastroenterol       Date:  2020-10-21       Impact factor: 5.742

4.  P16 and P53 Expression in Esophageal Squamous Cell Carcinoma: A Brief Report From The Experience of South of Iran, and Review of the Literature.

Authors:  Bita Geramizadeh; Alireza Mohammadian; Alireza Shojazadeh; Sahand Mohammadzadeh
Journal:  Clin Pathol       Date:  2021-05-20

Review 5.  Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.

Authors:  H A Hardefeldt; M R Cox; G D Eslick
Journal:  Epidemiol Infect       Date:  2014-06       Impact factor: 4.434

Review 6.  Prevalence and Association of Human Papillomavirus with Esophageal Squamous Cell Carcinoma in Iran: A Systematic Review and Meta-Analysis.

Authors:  Bashir Mohammadpour; Samaneh Rouhi; Mazaher Khodabandehloo; Masoud Moradi
Journal:  Iran J Public Health       Date:  2019-07       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.